Browsing: Huntingtons

uniQure has acknowledged that what it called “game changing” data in September showing significant slowing of Huntington’s disease (HD) progression…

Metal-organic frameworks and peripheral immune tolerance were the big winners of the Nobel prizes in chemistry, and in physiology or…

The dazzling 36-month clinical data announced by uniQure (NASDAQ: QURE) showing a significant slowing of Huntington’s disease (HD) progression in…

A gene therapy trial claims to show promising results for patients with Huntington’s disease. A press announcement of the experimental…

A brain scan of a person with Huntington’s disease, which causes a loss of brain volume as neurons are killed…

Study highlights functional preservation in patients and signals the potential for pre-symptomatic intervention. For decades Huntington’s disease has stood as…